Please login to the form below

human growth hormone

This page shows the latest human growth hormone news and features for those working in and with pharma, biotech and healthcare.

CHMP recommends Teva's generic version of Astellas' Advagraf

The committee also recommended that Faslodex could be used in combination with Pfizer ’s breast cancer drug Ibrance (palbociclib) to treat hormone receptor positive, human epidermal growth factor receptor 2-negative ... The combination can also be used

Latest news

Lilly gets early US approval for Ibrance rival abemaciclib

The US FDA has approved the CDK 4/6 inhibitor - which will be sold as Verzenio - as a combination treatment with hormone drug fulvestrant for hormone receptor-positive, human epidermal growth
Versartis crashes as VELOCITY trial veers off track

US biotech Versartis saw more than 80% wiped off its share price ahead of the weekend after its growth hormone deficiency drug somavaratan failed a phase III trial. ... The long-acting human growth hormone (hGH) product had been billed as a successor to
Surging Trulicity takes sting out of Lilly's arthritis setback

New chief executive David Ricks needs the drug and other growth brands to fire on all cylinders to help Lilly ride through the recent disappointment of a surprise FDA rejection for ... receptor-positive (HR+), human epidermal growth factor receptor
Pfizer keeps nose ahead of rivals with new Ibrance approval

The US FDA has converted its earlier conditional approval of Ibrance (palbociclib) into full approval as a first-line treatment of post-menopausal women with hormone receptor positive, human epidermal growth
FDA approval for Kisqali sets up showdown with Ibrance

menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

Implementing eHealth innovation

Medications management and eHealth. The reference treatment for patients with GHD is based on recombinant human growth hormone (rhGH) which is identical to the growth hormone produced by the pituitary gland. ... growth hormone deficiency, one in which
Pharma deals during December 2014

costs. Pfizer has also signed up to a drug delivery product this month through its $570m licensing deal with Opko Health for a long acting version of human growth hormone (hGH), ... which is currently in phase III trials for the treatment of growth

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Pharma and free medicines: a different perspective

Palbociclib is approved for the treatment of patients with locally advanced or metastatic breast cancer, specifically those who have hormone receptor-positive and human epidermal growth factor receptor 2-negative disease. ... The committee found that

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Graduate Scientific Editor: DOE

Medical Writer - Creative and Scientific Projects: DOE

Healthcare PR Director: £100, 000 – £120, 000 benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Senior Medical Writer: Salary is DOE

Senior Writer, Healthcare Advertising, London: Excellent package

Associate Scientific Director: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Systematic Review Lead- London: Negotiable

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Director or Senior Account Director: Salary TBC

Sudler London - Senior Medical Writer: Competitive

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Manager- 4 days per week or full-time: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Sudler London - Account Director: Competitive

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....